At a glance
ClinicalIndex Comparison RecordN/ACompleted· 42 enrolled
Drug / intervention
Rejuvenate Modular Hipdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Post-market, Multi-center Study of the Outcomes of the Rejuvenate® Modular Hip System
In Brief
A clinical study evaluating Rejuvenate Modular Hip for Arthroplasty, Replacement, Hip. Completed, enrolled 42 participants across 3 sites.
Detailed Summary
This study will be an evaluation of the Rejuvenate® Modular Hip System for primary total hip replacement (THR) with a cementless application in a consecutive series of patients who meet the eligibility criteria. Subjects will be evaluated for freedom of hip revision at 5 years and clinical outcomes for up to 10 years after surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArthroplasty, Replacement, Hip
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2010
First PostedDec 2010
Primary CompletionJun 2017
Study CompletionJan 2022
TodayJul 2026
First PostedDec 9, 2010
Enrollment StartNov 1, 2010
Primary CompletionJun 6, 2017
Study CompletionJan 20, 2022
TodayJul 2, 2026
Enrollment to primary: 6.6 yearsPosted 15.6 years ago
Interventions
Rejuvenate Modular Hipdevice
Rejuvenate Modular Hip